Global Urokinase Sales 麻豆原创 Report 2023

Publication ID:

PB501231989

Publication Date:

January 2, 2023

Pages:

120

Publisher:

MRRPB5

Countries:

Global [1]

USD 4,000.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
麻豆原创 Analysis and Insights: Global Urokinase 麻豆原创
Due to the COVID-19 pandemic, the global Urokinase market size is estimated to be worth US$ 45 million in 2022 and is forecast to a readjusted size of US$ 64 million by 2029 with a CAGR of 5.2% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Urokinase Powder accounting for % of the Urokinase global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Hospital segment is altered to an % CAGR throughout this forecast period.
Global Urokinase (CAS 9039-53-6) main manufactuers include Syner-Med, LIVZON, Wanhua Biochem and Techpool, totally accounting for about 50% of the market. China is the largest market of Urokinase (CAS 9039-53-6), holding a share about 56%. As for the types of products, it can be divided into urokinase powder and urokinase polution. The most common type is urokinase powder, with a share about 92%. As for the applications of products, it is widely used in hospitals, clinics and others. The most common application is in hospitals, with a share about 78%.
Global Urokinase Scope and 麻豆原创 Size
The global Urokinase market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Urokinase market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.
Segment by Type
Urokinase Powder
Urokinase Solution
Segment by Application
Hospital
Clinic
Others
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Syner-Med
Wanhua Biochem
Jiangxi Haoran Bio-Pharma
Jiangsu Aidea Pharmaceutical
Techpool
Microbic Biosystems
LIVZON

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Urokinase 麻豆原创 Overview
1.1 Urokinase Product Scope
1.2 Urokinase Segment by Type
1.2.1 Global Urokinase Sales by Type (2018 & 2022 & 2029)
1.2.2 Urokinase Powder
1.2.3 Urokinase Solution
1.3 Urokinase Segment by Application
1.3.1 Global Urokinase Sales Comparison by Application (2018 & 2022 & 2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Urokinase 麻豆原创 Estimates and Forecasts (2018-2029)
1.4.1 Global Urokinase 麻豆原创 Size in Value Growth Rate (2018-2029)
1.4.2 Global Urokinase 麻豆原创 Size in Volume Growth Rate (2018-2029)
1.4.3 Global Urokinase Price Trends (2018-2029)
2 Urokinase Estimates and Forecasts by Region
2.1 Global Urokinase 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2 Global Urokinase Retrospective 麻豆原创 Scenario by Region (2018-2023)
2.2.1 Global Urokinase Sales 麻豆原创 Share by Region (2018-2023)
2.2.2 Global Urokinase Revenue 麻豆原创 Share by Region (2018-2023)
2.3 Global Urokinase 麻豆原创 Estimates and Forecasts by Region (2024-2029)
2.3.1 Global Urokinase Sales Estimates and Forecasts by Region (2024-2029)
2.3.2 Global Urokinase Revenue Forecast by Region (2024-2029)
2.4 Geographic 麻豆原创 Analysis: 麻豆原创 Facts & Figures
2.4.1 United States Urokinase Estimates and Projections (2018-2029)
2.4.2 Europe Urokinase Estimates and Projections (2018-2029)
2.4.3 China Urokinase Estimates and Projections (2018-2029)
2.4.4 Japan Urokinase Estimates and Projections (2018-2029)
2.4.5 Southeast Asia Urokinase Estimates and Projections (2018-2029)
2.4.6 India Urokinase Estimates and Projections (2018-2029)
3 Global Urokinase Competition Landscape by Players
3.1 Global Top Urokinase Players by Sales (2018-2023)
3.2 Global Top Urokinase Players by Revenue (2018-2023)
3.3 Global Urokinase 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Urokinase as of 2022)
3.4 Global Urokinase Average Price by Company (2018-2023)
3.5 Manufacturers Urokinase Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Urokinase 麻豆原创 Size by Type
4.1 Global Urokinase Historic 麻豆原创 Review by Type (2018-2023)
4.1.1 Global Urokinase Sales by Type (2018-2023)
4.1.2 Global Urokinase Revenue by Type (2018-2023)
4.1.3 Global Urokinase Price by Type (2018-2023)
4.2 Global Urokinase 麻豆原创 Estimates and Forecasts by Type (2024-2029)
4.2.1 Global Urokinase Sales Forecast by Type (2024-2029)
4.2.2 Global Urokinase Revenue Forecast by Type (2024-2029)
4.2.3 Global Urokinase Price Forecast by Type (2024-2029)
5 Global Urokinase 麻豆原创 Size by Application
5.1 Global Urokinase Historic 麻豆原创 Review by Application (2018-2023)
5.1.1 Global Urokinase Sales by Application (2018-2023)
5.1.2 Global Urokinase Revenue by Application (2018-2023)
5.1.3 Global Urokinase Price by Application (2018-2023)
5.2 Global Urokinase 麻豆原创 Estimates and Forecasts by Application (2024-2029)
5.2.1 Global Urokinase Sales Forecast by Application (2024-2029)
5.2.2 Global Urokinase Revenue Forecast by Application (2024-2029)
5.2.3 Global Urokinase Price Forecast by Application (2024-2029)
6 United States Urokinase 麻豆原创 Facts & Figures
6.1 United States Urokinase Sales by Company
6.1.1 United States Urokinase Sales by Company (2018-2023)
6.1.2 United States Urokinase Revenue by Company (2018-2023)
6.2 United States Urokinase Sales Breakdown by Type
6.2.1 United States Urokinase Sales Breakdown by Type (2018-2023)
6.2.2 United States Urokinase Sales Breakdown by Type (2024-2029)
6.3 United States Urokinase Sales Breakdown by Application
6.3.1 United States Urokinase Sales Breakdown by Application (2018-2023)
6.3.2 United States Urokinase Sales Breakdown by Application (2024-2029)
7 Europe Urokinase 麻豆原创 Facts & Figures
7.1 Europe Urokinase Sales by Company
7.1.1 Europe Urokinase Sales by Company (2018-2023)
7.1.2 Europe Urokinase Revenue by Company (2018-2023)
7.2 Europe Urokinase Sales Breakdown by Type
7.2.1 Europe Urokinase Sales Breakdown by Type (2018-2023)
7.2.2 Europe Urokinase Sales Breakdown by Type (2024-2029)
7.3 Europe Urokinase Sales Breakdown by Application
7.3.1 Europe Urokinase Sales Breakdown by Application (2018-2023)
7.3.2 Europe Urokinase Sales Breakdown by Application (2024-2029)
8 China Urokinase 麻豆原创 Facts & Figures
8.1 China Urokinase Sales by Company
8.1.1 China Urokinase Sales by Company (2018-2023)
8.1.2 China Urokinase Revenue by Company (2018-2023)
8.2 China Urokinase Sales Breakdown by Type
8.2.1 China Urokinase Sales Breakdown by Type (2018-2023)
8.2.2 China Urokinase Sales Breakdown by Type (2024-2029)
8.3 China Urokinase Sales Breakdown by Application
8.3.1 China Urokinase Sales Breakdown by Application (2018-2023)
8.3.2 China Urokinase Sales Breakdown by Application (2024-2029)
9 Japan Urokinase 麻豆原创 Facts & Figures
9.1 Japan Urokinase Sales by Company
9.1.1 Japan Urokinase Sales by Company (2018-2023)
9.1.2 Japan Urokinase Revenue by Company (2018-2023)
9.2 Japan Urokinase Sales Breakdown by Type
9.2.1 Japan Urokinase Sales Breakdown by Type (2018-2023)
9.2.2 Japan Urokinase Sales Breakdown by Type (2024-2029)
9.3 Japan Urokinase Sales Breakdown by Application
9.3.1 Japan Urokinase Sales Breakdown by Application (2018-2023)
9.3.2 Japan Urokinase Sales Breakdown by Application (2024-2029)
10 Southeast Asia Urokinase 麻豆原创 Facts & Figures
10.1 Southeast Asia Urokinase Sales by Company
10.1.1 Southeast Asia Urokinase Sales by Company (2018-2023)
10.1.2 Southeast Asia Urokinase Revenue by Company (2018-2023)
10.2 Southeast Asia Urokinase Sales Breakdown by Type
10.2.1 Southeast Asia Urokinase Sales Breakdown by Type (2018-2023)
10.2.2 Southeast Asia Urokinase Sales Breakdown by Type (2024-2029)
10.3 Southeast Asia Urokinase Sales Breakdown by Application
10.3.1 Southeast Asia Urokinase Sales Breakdown by Application (2018-2023)
10.3.2 Southeast Asia Urokinase Sales Breakdown by Application (2024-2029)
11 India Urokinase 麻豆原创 Facts & Figures
11.1 India Urokinase Sales by Company
11.1.1 India Urokinase Sales by Company (2018-2023)
11.1.2 India Urokinase Revenue by Company (2018-2023)
11.2 India Urokinase Sales Breakdown by Type
11.2.1 India Urokinase Sales Breakdown by Type (2018-2023)
11.2.2 India Urokinase Sales Breakdown by Type (2024-2029)
11.3 India Urokinase Sales Breakdown by Application
11.3.1 India Urokinase Sales Breakdown by Application (2018-2023)
11.3.2 India Urokinase Sales Breakdown by Application (2024-2029)
12 Company Profiles and Key Figures in Urokinase Business
12.1 Syner-Med
12.1.1 Syner-Med Corporation Information
12.1.2 Syner-Med Business Overview
12.1.3 Syner-Med Urokinase Sales, Revenue and Gross Margin (2018-2023)
12.1.4 Syner-Med Urokinase Products Offered
12.1.5 Syner-Med Recent Development
12.2 Wanhua Biochem
12.2.1 Wanhua Biochem Corporation Information
12.2.2 Wanhua Biochem Business Overview
12.2.3 Wanhua Biochem Urokinase Sales, Revenue and Gross Margin (2018-2023)
12.2.4 Wanhua Biochem Urokinase Products Offered
12.2.5 Wanhua Biochem Recent Development
12.3 Jiangxi Haoran Bio-Pharma
12.3.1 Jiangxi Haoran Bio-Pharma Corporation Information
12.3.2 Jiangxi Haoran Bio-Pharma Business Overview
12.3.3 Jiangxi Haoran Bio-Pharma Urokinase Sales, Revenue and Gross Margin (2018-2023)
12.3.4 Jiangxi Haoran Bio-Pharma Urokinase Products Offered
12.3.5 Jiangxi Haoran Bio-Pharma Recent Development
12.4 Jiangsu Aidea Pharmaceutical
12.4.1 Jiangsu Aidea Pharmaceutical Corporation Information
12.4.2 Jiangsu Aidea Pharmaceutical Business Overview
12.4.3 Jiangsu Aidea Pharmaceutical Urokinase Sales, Revenue and Gross Margin (2018-2023)
12.4.4 Jiangsu Aidea Pharmaceutical Urokinase Products Offered
12.4.5 Jiangsu Aidea Pharmaceutical Recent Development
12.5 Techpool
12.5.1 Techpool Corporation Information
12.5.2 Techpool Business Overview
12.5.3 Techpool Urokinase Sales, Revenue and Gross Margin (2018-2023)
12.5.4 Techpool Urokinase Products Offered
12.5.5 Techpool Recent Development
12.6 Microbic Biosystems
12.6.1 Microbic Biosystems Corporation Information
12.6.2 Microbic Biosystems Business Overview
12.6.3 Microbic Biosystems Urokinase Sales, Revenue and Gross Margin (2018-2023)
12.6.4 Microbic Biosystems Urokinase Products Offered
12.6.5 Microbic Biosystems Recent Development
12.7 LIVZON
12.7.1 LIVZON Corporation Information
12.7.2 LIVZON Business Overview
12.7.3 LIVZON Urokinase Sales, Revenue and Gross Margin (2018-2023)
12.7.4 LIVZON Urokinase Products Offered
12.7.5 LIVZON Recent Development
13 Urokinase Manufacturing Cost Analysis
13.1 Urokinase Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Urokinase
13.4 Urokinase Industrial Chain Analysis
14 麻豆原创ing Channel, Distributors and Customers
14.1 麻豆原创ing Channel
14.2 Urokinase Distributors List
14.3 Urokinase Customers
15 麻豆原创 Dynamics
15.1 Urokinase Industry Trends
15.2 Urokinase 麻豆原创 Drivers
15.3 Urokinase 麻豆原创 Challenges
15.4 Urokinase 麻豆原创 Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

Companies Mentioned:

Syner-Med
Wanhua Biochem
Jiangxi Haoran Bio-Pharma
Jiangsu Aidea Pharmaceutical
Techpool
Microbic Biosystems
LIVZON

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.